1/48
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
proto-oncogene
normal gene, frequently linked to the regulation of cell proliferation
oncogene
gene whose protein product can make cells cancerous when it is overexpressed or mutated
oncoprotein
protein encoded by an oncogene that can cause transformation of a cell into a tumor cell
retrovirus
has RNA genome; replicates by making an RNA-DNA hybrid and then double-stranded DNA which gets integrated into host chromosomes
transformation
how a cell becomes cancerous
double minute chromosomes
cytogenetic hallmarks of genomic amplification in cancer
ErbA
nuclear receptor family of TFs
trans-splicing
enables ligation of exons from different pre-mRNAs into a single transcript
tumor suppressor genes
prevents cancer
retinoblastoma protein
tumor suppressor
inhibits activation by TF E2F
recruits HDACs and histone methylases
wild-type
gene that occurs most frequently in the population
quenching
any process that decreases Fluorescence intensity of Fluorophores
DNA tumor viruses
agents that cause malignancies in a large variety of cell types and tissues by interfering with cell cycle control and immortalization
haploid insufficiency
disease in which one copy of a gene is mutated and the remaining wild type copy cannot produce sufficient functional protein to prevent disease
triplet repeat diseases
diseases involving the abnormal amplification of a three base pair sequence
RNA translation
process through which info encoded in mRNA directs the addition of amino acids during protein synthesis
interferon
class of cytokines secreted by virus-infected cells and certain T cells
induce antiviral responses by activating JAK/STAT pathway to turn in antiviral genes
BRD4
the most important functional protein in the bromodomain and super terminal family protein
designer zinc finger
switch expression on or off
RNA interference
cellular mechanism that uses the gene’s own DNA sequence to turn it off
how do viruses manipulate gene expression?
they have possession of regulatory signals within viral mRNAs that are recognizable by the host cell. Enables virus to shut off host gene expression to ensure preferential viral gene expression
what are some triplet repeat diseases?
Rubinstein-Taybi syndrome
SCA7
fragile X syndrome
Huntingtin’s disease
Type 1 Myotonic dystrophy
details of Rubinstein-Taybi syndrome
condition characterized by short stature, moderate to severe learning difficulties, distinctive facial features, and broad thumbs and first toes
single gene inactivation
mutated Huntingtin binds normal CBP, TBP and SP1
CAG expanded in Huntingtin coding sequence resulting in a run of glutamines
details of SCA 7 disease
mutant ataxin has a CAG repeat
this results in a stretch of polyglutamine
the mutant form is a dominant negative inhibitor of the wild-type ataxin
the mutant blocks wild-type ataxin from opening chromatin via acetylation
details of fragile X syndrome
FMR-1 wild-type has 10-50 tandem copies of CGG
get transcription with wild-type
FMR-1 mutant is methylated
get >230 tandem copies of extended CGG repeat in first exon
get no transcription with mutant
details of type 1 myotonic dystrophy
CUG repeats sequesters alternative splicing factor so it can’t bind its normal RNA targets
sequestration of alternative splicing factor, and loss of its normal function
details of Huntingtin’s disease
RAN translation
repeats hinder initiation at AUG
abnormal proteins are produced
translation proceeds normally→ poly Q
what genes are regulated by p53?
genes whose proteins inhibit growth
genes whose proteins stimulate growth
what is p53?
a transcription factor
induced by DNA damage
mutated in many cancers
can induce growth arrest
how does p53 repress GSGs?
direct mechanisms
compete for activator binding sites
close chromatin
bind up activators
indirect mechanisms
p21
turn on miRNAs
turn on IncRNAs
what is p21?
inhibits cyclin-dependent kinases needed for growth
growth arrest gene
how is p53 activity thwarted?
gene gets deleted
mutant p53 gene
intact p53 gene with amplified MDM2 oncogene
what can mutant p53 bind?
alternative sequences in promoters that wild-type p53 won’t
other TFs
what happens when MDM2 binds to p53?
partial ubquitination
export from nucleus
what happens when MDM2 binds to partially ubquitinated p53?
degradation of p53
what does MDM4 do?
inhibits p53 by binding its activation domain
how can p53 evade MDM2?
via acetylation which
inhibits MDM2 interaction
recruits TAF1
what does p53 promote?
p21
Bax
MDM2
what does p53 repress?
Nanog
what does increased p21 lead to?
increased growth arrest
what does increased Bax lead to?
increased cell death
what does decreased Nanog lead to?
increased differentiation
what does increased MDM2 lead to?
increased suppression of p53
What is RAN translation?
repeat associated non-AUG
repeats hinder initiation at AUG
Abnormal proteins are produced
what mechanisms does V-ErbA use to regulate gene expression?
dominant repressor
blocks hormone-dependent gene expression
inhibitory domain that recruits a co-repressor
inhibitory domain is essential for transformation
must repress transcription to transform
repression required to turn off this terminal developmental process
what mechanisms does Myc use to regulate gene expression?
bind to max to get DNA binding and enhanced transcriptional initiation
bind to PTEF-b to get enhanced transcriptional elongation
bind TFIIH to get GMT and enhanced translation
what mechanisms does MDM2 and MDM4 use to regulate gene expression?
inactivates p53 expression
bind L26 to get reduced translation
MDM4 inhibits p53 by binding its activation domain
How would you cure a transcriptional disease?
alter TF activity by promoting or inhibiting post-translation modifications
alter TF activity by promoting or inhibiting protein:protein interactions
target chromatin modifying proteins
target epigenetic modifications
nucleic acid-based therapies
designer zinc fingers to switch expression off or on
what type of factors that regulate gene expression can be mutated in human diseases?
transcription
chromatin structure
post-transcriptional
regulatory RNAs
infectious disease